Supplementary Materials

The PDF file includes:

  • Fig S1. JAKi does not affect cortical bone parameters or bone cell numbers under steady-state conditions.
  • Fig S2. Confirmation of OVX and cortical bone effects of JAKi after OVX.
  • Fig S3. Effects of JAKi on arthritis-mediated bone loss.
  • Fig S4. Gene network changes in MSCs during JAKi.
  • Fig. S5. Proposed model for the role of JAKi by baricitinib and tofacitinib in osteoblasts.
  • Table S1. Genetic targets and primers used for qPCR.
  • Table S2. Protein targets, antibodies, and control extracts used for Western blot analysis.

[Download PDF]

Other Supplementary Material for this manuscript includes the following: